Colin H Quinn

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 12

Top Topics

Cell Cycle Arrest

Herpes Simplex Virus

Dna Damage Response

Top Venues

International journal of molecular sciences

Cancer gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Amber B Jones, Kaysaw Tuy, Cyntanna C Hawkins, Colin H Quinn, Joelle Saad, Sam E Gary, Elizabeth Ann Beierle, Lei Ding, Kate M Rochlin, Lawrence S Lamb, Anita B Hjelmeland
Temozolomide and the PARP Inhibitor Niraparib Enhance Expression of Natural Killer Group 2D Ligand ULBP1 and Gamma-Delta T Cell Cytotoxicity in Glioblastoma. Cancers 16 (16) (2024)
Amber B Jones, Kaysaw Tuy, Cyntanna C Hawkins, Colin H Quinn, Joelle Saad, Sam E Gary, Elizabeth Ann Beierle, Lei Ding, Kate M Rochlin, Lawrence S Lamb, Anita B Hjelmeland
Temozolomide and the PARP Inhibitor Niraparib Enhance Expression of Natural Killer Group 2D Ligand ULBP1 and Gamma-Delta T Cell Cytotoxicity in Glioblastoma. Cancers 16 (16) (2024)
Janet Rae Julson, Colin H Quinn, Swatika Butey, Michael H Erwin, Raoud Marayati, Nazia Nazam, Jerry E Stewart, Elizabeth Ann Beierle
PIM Kinase Inhibition Attenuates the Malignant Progression of Metastatic Hepatoblastoma. International journal of molecular sciences 25 (1) (2023)
Janet Rae Julson, Colin H Quinn, Swatika Butey, Michael H Erwin, Raoud Marayati, Nazia Nazam, Jerry E Stewart, Elizabeth Ann Beierle
PIM Kinase Inhibition Attenuates the Malignant Progression of Metastatic Hepatoblastoma. International journal of molecular sciences 25 (1) (2023)
Janet Rae Julson, Colin H Quinn, Swatika Butey, Michael H Erwin, Raoud Marayati, Nazia Nazam, Jerry E Stewart, Elizabeth Ann Beierle
PIM Kinase Inhibition Attenuates the Malignant Progression of Metastatic Hepatoblastoma. International journal of molecular sciences 25 (1) (2023)
Janet Rae Julson, Colin H Quinn, Swatika Butey, Michael H Erwin, Raoud Marayati, Nazia Nazam, Jerry E Stewart, Elizabeth Ann Beierle
PIM Kinase Inhibition Attenuates the Malignant Progression of Metastatic Hepatoblastoma. International journal of molecular sciences 25 (1) (2023)
Laura V Bownes, Raoud Marayati, Colin H Quinn, Andee M Beierle, Sara C Hutchins, Janet R Julson, Michael H Erwin, Jerry E Stewart, Elizabeth Mroczek-Musulman, Michael Ohlmeyer, Jamie M Aye, Karina J Yoon, Elizabeth Ann Beierle
Pre-Clinical Study Evaluating Novel Protein Phosphatase 2A Activators as Therapeutics for Neuroblastoma. Cancers 14 (8) (2022)
Colin H Quinn, Andee M Beierle, Sara Claire Hutchins, Raoud Marayati, Laura V Bownes, Jerry E Stewart, Hooper R Markert, Michael H Erwin, Jamie M Aye, Karina J Yoon, Gregory K Friedman, Christopher D Willey, James M Markert, Elizabeth Ann Beierle
Targeting High-Risk Neuroblastoma Patient-Derived Xenografts with Oncolytic Virotherapy. Cancers 14 (3) (2022)
Laura V Bownes, Adele P Williams, Raoud Marayati, Colin H Quinn, Sara C Hutchins, Jerry E Stewart, Trung Vu, Juliet L Easlick, Elizabeth Mroczek-Musulman, David K Crossman, Joshua C Anderson, Christopher D Willey, Pran K Datta, Elizabeth Ann Beierle
Serine-Threonine Kinase Receptor-Associated Protein (STRAP) Knockout Decreases the Malignant Phenotype in Neuroblastoma Cell Lines. Cancers 13 (13) (2021)
Raoud Marayati, Laura L Stafman, Adele P Williams, Laura V Bownes, Colin H Quinn, Hooper R Markert, Juliet L Easlick, Jerry E Stewart, David K Crossman, Elizabeth Mroczek-Musulman, Elizabeth Ann Beierle
CRISPR/Cas9-mediated knockout of PIM3 suppresses tumorigenesis and cancer cell stemness in human hepatoblastoma cells. Cancer gene therapy (2021)
Colin H Quinn, Andee M Beierle, Elizabeth Ann Beierle
Artificial Tumor Microenvironments in Neuroblastoma. Cancers 13 (7) (2021)
Raoud Marayati, Colin H Quinn, Elizabeth Ann Beierle
Immunotherapy in Pediatric Solid Tumors-A Systematic Review. Cancers 11 (12) (2019)